Individual factors increasing complexity of drug treatment—a narrative review Steffen J. SchmidtViktoria S. WurmbachPetra A. Thürmann Review Open access 01 April 2020 Pages: 745 - 754
The implementation of health technology assessment principles in public decisions concerning orphan drugs Elenka BrennaBarbara PolistenaFederico Spandonaro Review 26 March 2020 Pages: 755 - 764
Tocilizumab in transplantation Banafsheh MosharmovahedYousef FatahiSara Assadiasl Review 08 April 2020 Pages: 765 - 773
Facilitators and barriers for performing comprehensive medication reviews and follow-up by multiprofessional teams in older hospitalised patients Thomas Gerardus Hendrik KempenAmanda KälvemarkUlrika Gillespie Clinical Trial Open access 19 February 2020 Pages: 775 - 784
Pharmacokinetics, pharmacodynamics, safety, tolerability, and mass balance of single and continuous intravenous infusion of SPT-07A in healthy volunteers Weicong WangYan WangXia Chen Clinical Trial 09 March 2020 Pages: 785 - 793
Association of tiotropium use and the risk of adverse cardiovascular events in patients with chronic obstructive pulmonary disease: a meta-analysis of randomized controlled trials Mingjin YangYan ZhangJianqing He Pharmacodynamics 10 April 2020 Pages: 795 - 805
Association between functional polymorphisms in serotonin transporter gene (SLC6A4) and escitalopram treatment response in depressive patients in a South Indian population Tatiyana MandalLaxminarayana Kurady BairyPodila Satya Venkata Narasimha Sharma Pharmacogenetics 06 April 2020 Pages: 807 - 814
Extracorporeal treatment of metforminassociated lactic acidosis in clinical practice: a retrospective cohort study Inge R.F. van Berlo-van de LaarCornelis G. VermeijFrank G.A. Jansman Pharmacokinetics and Disposition Open access 13 March 2020 Pages: 815 - 820
Utilizing physiologically based pharmacokinetic modeling to predict theoretically conceivable extreme elevation of serum flecainide concentration in an anuric hemodialysis patient with cirrhosis Kosuke DokiKeisuke KugaMasato Homma Pharmacokinetics and Disposition 05 April 2020 Pages: 821 - 831
Effect of proton pump inhibitors on voriconazole concentrations in Chinese patients with malignant hematological diseases Qi HuangQiong LiuYueping Jiang Pharmacoepidemiology and Prescription 10 March 2020 Pages: 833 - 842
Cancer drugs for solid tumors approved by the EMA since 2014: an overview of pivotal clinical trials Ruggero LasalaAndrea LogrecoAlberto Costantini Pharmacoepidemiology and Prescription 03 March 2020 Pages: 843 - 850
Proton pump inhibitors and risk of liver cancer and mortality in patients with chronic liver disease: a systematic review and meta-analysis Hyun Jin SongXinyi JiangHaesuk Park Pharmacoepidemiology and Prescription 14 March 2020 Pages: 851 - 866
Risk factors for severe bleeding events during warfarin treatment: the influence of sex, age, comorbidity and co-medication Diana M. RydbergMarie LinderMorten Andersen Pharmacoepidemiology and Prescription Open access 28 March 2020 Pages: 867 - 876
Prescribing medications of questionable benefit prior to death: a retrospective study on older nursing home residents with and without dementia in Germany Christian RauschFalk Hoffmann Pharmacoepidemiology and Prescription Open access 26 March 2020 Pages: 877 - 885
Prescription medicines with potential for foetal harm: dispensing before and during pregnancy in New Zealand, 2005–2015 Sarah DonaldKatrina SharplesLianne Parkin Pharmacoepidemiology and Prescription 04 April 2020 Pages: 887 - 896
Lack of evidence for allopurinol for the prevention of a first gout attack in asymptomatic hyperuricemia: a systematic review A. HazardB. BourrionM. François Letter to the Editor 25 February 2020 Pages: 897 - 899
Clomiphene misuse and risk of severe cardiovascular events Céline EidenVéronique PinzaniHélène Peyrière Letter to the Editor 17 March 2020 Pages: 901 - 902
